Nathan J. Dowden, President & COO at Entrada Therapeutics, Inc. (TRDA), sold 2,303 shares at $15.19 ($35K) on 2024-09-06, disclosed to the SEC on 2024-09-10.
Scheduled sale ($35k) by President & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.19 | 399 | $6K | 17.4% |
| 2 | $15.07 | 1,904 | $29K | 82.6% |
| Total | $15.09 avg | 2,303 | $35K | 100% |
| Filing → |
| TRDA | SELL | 2024-09-30 | $14K | — | Filing → |
| TRDA | SELL | 2024-08-20 | $873K | — | Filing → |
| TRDA | SELL | 2024-03-08 | $22K | — | Filing → |